Ginger (Zingiber officinale) as anti-emetic prophylaxis for chemotherapy-induced nausea and vomiting

Not Applicable

Completed

• Conditions: Signs and Symptoms: Nausea and vomiting; Signs and Symptoms; Nausea and vomiting

• Registration Number: ISRCTN11623624
• Lead Sponsor: Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-05-01
• Study Start: 2005-09-30
• Last Update Posted: 20 April 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 118

Inclusion Criteria

118 cancer patients

Exclusion Criteria

1. Any prior chemotherapy
2. Anticipatory nausea/vomiting
3. Concurrent use of products containing ginger or ginger preparations
4. Concurrent use of any other experimental drugs
5. Clinical or radiological evidence of cerebral metastases
6. Clinical or radiological evidence of intestinal obstruction; any profound metabolic disturbance liable to cause nausea and vomiting (hypercalcaemia, diabetic ketoacidosis etc)
7. Any history of hypersensitivity to ginger
8. Any condition precluding the use of standard antiemetic therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified